Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.
Press releases published on June 23, 2025
Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders
GlobeNewswire
·
June 23, 2025
TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Friday, June 20, 2025 (the “Meeting”), shareholders holding a total of …
Lyell Immunopharma to Participate in the H.C. Wainwright “HCW@Home” Series
GlobeNewswire
·
June 23, 2025
SOUTH SAN FRANCISCO, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing next-generation CAR T-cell therapies for patients with cancer, announced today that members of its senior management …
Scilex Holding Company Announces Deferral of Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from May 2, 2025 to…
GlobeNewswire
·
June 23, 2025
PALO ALTO, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the …
Jushi and Real Housewives Star Stacey Rusch Celebrate Successful Launch of Lifestyle Cannabis Brand ‘Shayo’
GlobeNewswire
·
June 23, 2025
(Photo credit: Andreas Neumann) BOCA RATON, Fla., June 23, 2025 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF) has partnered with entrepreneur, philanthropist, and Real Housewives of Potomac star Stacey Rusch …
Onco360 Has Been Selected as a National Specialty Pharmacy Partner for ROMVIMZA™ (vimseltinib)
GlobeNewswire
·
June 23, 2025
LOUISVILLE, Ky., June 23, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a specialty pharmacy partner by Deciphera Pharmaceuticals, LLC for ROMVIMZA™ (vimseltinib), which has been approved by …
Cidara Announces Proposed Public Offering of Common Stock
GlobeNewswire
·
June 23, 2025
SAN DIEGO, June 23, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (“Cidara”) (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced its plans to commence an …
Natural Alternatives International, Inc. Announces Amended and Extended Credit Facility with Wells Fargo Bank
GlobeNewswire
·
June 23, 2025
CARLSBAD, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced the execution of an amended credit …
Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 23, 2025
FLORHAM PARK, N.J., June 23, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that, in …
Terns Pharmaceuticals Presents Positive Data from Phase 1 Study of TERN-601 Once-daily Oral GLP-1R Agonist for Treatment of Obesity at 85th Annual American Diabetes Association Scientific Sessions
GlobeNewswire
·
June 23, 2025
Phase 1 clinical study of TERN-601 demonstrated differentiated profile in 28-day study; topline data were presented in September 2024 Phase 2 FALCON clinical trial of TERN-601 completed enrollment; 12-week data expected in 4Q 2025 FOSTER CITY, Calif., June …
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
GlobeNewswire
·
June 23, 2025
NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative …
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
·
June 23, 2025
SAN CARLOS, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL …
iMDx Reports Strong Head-to-Head Data in Kidney Transplant Rejection Testing
GlobeNewswire
·
June 23, 2025
Study indicates iMDx flagship technology’s equivalence with commercially available dd-cfDNA test kits Head-to-head comparison of iMDx’s digital PCR-based test kits with NGS kits shows consistent results in 96 transplant patients Data was presented at the …
Stage4Hope™ Launches to Transform the Advanced-Stage Cancer Experience
GlobeNewswire
·
June 23, 2025
ATLANTA, June 23, 2025 (GLOBE NEWSWIRE) -- Stage4Hope™, a 501(c)(3) public charity, officially launches this month with a powerful mission: to improve the lives of individuals diagnosed with advanced-stage cancer by accelerating access to world-class …
SickKids staff to join hospital workers across Ontario as members of the Healthcare of Ontario Pension Plan (HOOPP)
GlobeNewswire
·
June 23, 2025
TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- The Healthcare of Ontario Pension Plan (HOOPP) and The Hospital for Sick Children (SickKids) are pleased to announce that SickKids employees will become members of HOOPP’s defined benefit pension plan, effective …
Bioma Probiotics Officially Launches: A Revolutionary Step Toward Total Gut Health
GlobeNewswire
·
June 23, 2025
new york City, NY, June 23, 2025 (GLOBE NEWSWIRE) -- Bioma Probiotics In a bold move to reshape the way people think about gut health and overall wellness, Bioma, a leading-edge nutraceutical company, has officially launched its flagship product: Bioma …
HepatoBurn 2025: Experts Discuss the Mitochondrial Science Behind Hepato Burn Emerging Weight Support Formula
GlobeNewswire
·
June 23, 2025
New York City, NY, June 23, 2025 (GLOBE NEWSWIRE) -- In 2025, the conversation around weight management has evolved far beyond calorie counting and cardio routines. An emerging supplement known as HepatoBurn is generating significant interest for its …
Codiant Powers Up Wellness with CalCounts, A Science-Driven AI Calorie Tracking App
EIN Presswire
·
June 23, 2025
Codiant has launched CalCounts, a science-backed, AI-powered Calorie Count app that simplifies calorie and macro tracking through meal photo and barcode scans. IL, UNITED STATES, June 23, 2025 /EINPresswire.com/ -- Let’s be honest. Most calorie-tracking …
Simple Divorce Releases New Study on Impact of Economic Factors on Divorce Rates in Ontario
GlobeNewswire
·
June 23, 2025
Toronto, Ontario, June 23, 2025 (GLOBE NEWSWIRE) -- A recent study from Simple Divorce has uncovered a compelling connection between financial stress and increasing divorce rates across Ontario. The findings shine a spotlight on how inflation, job …
ACADEMY OF NUTRITION AND DIETETICS ANNOUNCES REGISTERED DIETITIAN NUTRIONIST, CHEF, AUTHOR AND TV HOST ELLIE KRIEGER AS 2025 FOOD & NUTRITION CONFERENCE & EXPO® KEYNOTE SPEAKER
GlobeNewswire
·
June 23, 2025
Chicago, June 23, 2025 (GLOBE NEWSWIRE) -- Food and nutrition experts from around the world will gather in Nashville, Tenn., October 11-14, for the Academy of Nutrition and Dietetics’ 2025 Food …
Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
GlobeNewswire
·
June 23, 2025
Groundbreaking First-in-Human Study Establishes Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without Immunosuppression Six-Month Patient Follow-up Results Demonstrate that Sana’s Transplanted Pancreatic Islet Cells Modified …